IgA autoantibodies specifically recognize the epidermal transglutaminase (TG3) and cross-react with tissue transglutaminase (TG2) and are a useful marker of bowel damage and diet adherence in DH/celiac disease patients (Table 2) [166, 167]. This evidence concerns the gene TGM2 and celiac disease.